CN114796430A - Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus - Google Patents

Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus Download PDF

Info

Publication number
CN114796430A
CN114796430A CN202210422176.0A CN202210422176A CN114796430A CN 114796430 A CN114796430 A CN 114796430A CN 202210422176 A CN202210422176 A CN 202210422176A CN 114796430 A CN114796430 A CN 114796430A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
raw
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210422176.0A
Other languages
Chinese (zh)
Inventor
丁佳胜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202210422176.0A priority Critical patent/CN114796430A/en
Publication of CN114796430A publication Critical patent/CN114796430A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964—Anemarrhena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9064—Amomum, e.g. round cardamom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine formula with a prevention and treatment effect on 2019 novel coronavirus, which is mainly prepared from raw material medicines such as bran-fried rhizoma atractylodis, ginger-processed magnolia bark, dried orange peel, honey-fried licorice root, dried ginger, fructus aurantii, platycodon grandiflorum, raw white paeony root, raw liquorice root, radix bupleuri, cassia twig, codonopsis pilosula, perilla leaf and the like, and belongs to the technical field of medicines. According to the characteristics of 2019 coronavirus diseases, the formula of the invention applies the theory of traditional Chinese medicine, and the whole formula has the effects of encouraging qi of heart, spleen and lung to defend against external pathogens, releasing exterior with pungent and warm natured drugs to ventilate cold pathogens, eliminating phlegm and clearing heat and toxic materials to dispel internal pathogens, thereby having the effects of preventing and treating 2019 novel coronavirus.

Description

Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine formula with a prevention and treatment effect on 2019 novel coronavirus.
Background
The novel coronavirus pneumonia is named as '2019 coronavirus disease' by the world health organization. It is mainly manifested by fever, dry cough, asthenia, etc., and a few patients are accompanied by upper respiratory tract and digestive tract symptoms such as nasal obstruction, watery nasal discharge, diarrhea, etc.
The novel coronavirus pneumonia belongs to the category of cold-dampness (plague) epidemic in traditional Chinese medicine according to the traditional Chinese medicine theory, and is treated by a method of dispelling cold pathogen through warm-dispersing and exterior-releasing with pungent and warm natured herbs and treating dampness pathogen by avoiding dirt with aromatics and dissolving turbidity with aromatics as a treatment rule; furthermore, epidemic pertains to exogenous pathogenic factors, and it is reported in Zhongyan (Huangdi's classic of internal medicine and Su Wen she): the healthy qi exists in the interior, and the pathogenic factors cannot dry out; when the pathogenic qi is weakened, the healthy qi is complemented to prevent the exogenous pathogenic factors, which is the prevention rule.
Disclosure of Invention
Under the guidance of the traditional Chinese medicine theory, a traditional Chinese medicine formula with prevention and treatment effects on 2019 novel coronavirus is combined, and the invention is realized by the following technical scheme:
selecting the following raw material medicines: 3-9 parts of bran-fried rhizoma atractylodis, 3-9 parts of cortex magnoliae officinalis, 3-9 parts of pericarpium citri reticulatae, 3-9 parts of honey-fried licorice root, 3-9 parts of rhizoma zingiberis, 3-9 parts of fructus aurantii, 3-9 parts of platycodon grandiflorum, 6-15 parts of raw radix paeoniae alba, 6-9 parts of raw liquorice, 3-9 parts of radix bupleuri, 3-9 parts of cassia twig, 9-30 parts of codonopsis pilosula, 6-9 parts of perilla leaf, 6-12 parts of rhizoma anemarrhenae, 6-9 parts of schizonepeta spike, 6-12 parts of cortex mori radicis, 3-9 parts of sappan wood, 3-6 parts of fructus tsaoko, 6-9 parts of rhizoma dryopteris crassirhizomae and 9-15 parts of polygonum cuspidatum.
The raw materials of the traditional Chinese medicine formula of the invention are added with pharmaceutically acceptable excipients according to the conventional process to prepare clinically acceptable dosage forms: such as tablets, granules, capsules, pills, oral liquid, injections, freeze-dried powders, various sustained-release preparations and the like; the raw materials of the traditional Chinese medicine formula can be directly crushed into powder, heated for aromatherapy or made into sachets for wearing; the raw materials of the traditional Chinese medicine formula can be directly decocted with water for administration or fumigated.
The traditional Chinese medicine formula of the invention is defined as follows:
stir-baked rhizoma atractylodis with bran, officinal magnolia bark with ginger, dried orange peel and honey-fried licorice root, take the meaning of Ping Wei san from Song, Tai Ping Hui Min He Ji Ju Fang, dry dampness and activate spleen, move qi and harmonize stomach. The spleen and stomach are the acquired root and the source of qi and blood generation, so that they are not interfered by exogenous pathogenic factors.
Dried ginger and prepared licorice root, Zhongjing Licorice dried ginger decoction, the two herbs are used together, pungent and sweet to resolve yang, so as to stimulate middle-jiao yang, warm lung and replenish qi.
Fructus Aurantii, Platycodon grandiflorum, and radix Paeoniae alba are used as the main ingredients for pus discharge, and phlegm is also pus discharge. Fructus Aurantii and radix Paeoniae alba can relieve smooth muscle spasm, and radix Platycodi can dilute phlegm and discharge phlegm and fluid.
Raw licorice and root of balloonflower, Zhongjing Jiefeng Tang, are used for treating sore throat due to heat-toxin.
Radix bupleuri, radix glycyrrhizae preparata, fructus aurantii and raw radix paeoniae alba, the Zhongjing Siadverse-rising energy-dissipating meaning is selected, pathogenic factors are penetrated, depression is relieved, the liver is soothed and the spleen is regulated, pathogenic factors are relieved, qi and blood are regulated smoothly, and yang is cleared to stretch and circulate qi.
Ramulus Cinnamomi and radix Glycyrrhizae Preparata, the formula of Zhongjing ramulus Cinnamomi and radix Glycyrrhizae decoction is used to stimulate heart yang.
Cassia twig, radix codonopsitis, rhizoma atractylodis stir-fried with bran, honey-fried licorice root and dried ginger, which take the meaning of Zhongjing cassia twig and ginseng decoction, and tonify spleen and qi.
Perilla leaf, Anemarrhena asphodeloides, Schizonepeta tenuifolia and Morus alba bark, in Yinqiao san from Wen Bing tiao Bian, they have the actions of relieving exterior syndrome, clearing heat and removing toxicity. In the original prescription, forsythia is used as rhizoma anemarrhenae and honeysuckle is used as cortex mori radicis to enhance the effects of clearing heat and removing toxicity.
Caesalpinia sappan and radix codonopsitis can remove the septicemia in the lung.
Caoguo, fragrant, avoiding filth and transforming turbidity.
Rhizoma Dryopteris Crassirhizomatis, which is called Xian Dan for removing toxicity in terms of "materia Medica New compilation". The toxicity is not reached and can be prevented, the toxicity is reached and can be relieved well, and the toxicity can be removed quickly.
Giant knotweed rhizome has the function of inhibiting viruses and bacteria.
The traditional Chinese medicine is used according to the formula, so that yang of heart and lung of a human body is excited, spleen qi is healthy and healthy, qi movement is smooth, vital qi is full, pathogenic factors cannot be dried, exterior syndrome is relieved, cold pathogenic factors are eliminated, exogenous pathogenic factors are eliminated, aroma is removed, turbid is removed, phlegm is eliminated, heat is removed, toxin is removed, and internal pathogenic factors cannot be stored, so that the traditional Chinese medicine has a prevention and treatment effect on 2019 novel coronavirus.
Detailed Description
Example 1:
9g of rhizoma atractylodis stir-fried with bran, 9g of cortex magnoliae officinalis processed with ginger, 9g of pericarpium citri reticulatae, 9g of radix glycyrrhizae preparata, 9g of rhizoma zingiberis, 9g of fructus aurantii, 9g of platycodon grandiflorum, 9g of raw radix paeoniae alba, 9g of raw liquorice, 9g of radix bupleuri, 9g of cassia twig, 15g of codonopsis pilosula, 9g of perilla leaf, 6g of rhizoma anemarrhenae, 9g of schizonepeta spike, 6g of cortex mori radicis, 9g of sappan wood, 6g of fructus tsaoko, 9g of rhizoma dryopteris crassirhizomae and 9g of polygonum cuspidatum.
The medicine is prepared into 300ml decoction which is taken once in the morning and at night, 150ml is taken each time, and 7 days is a treatment course.
Example 2:
9g of rhizoma atractylodis stir-fried with bran, 9g of cortex magnoliae officinalis processed with ginger, 9g of pericarpium citri reticulatae, 9g of radix glycyrrhizae preparata, 9g of rhizoma zingiberis, 9g of fructus aurantii, 9g of platycodon grandiflorum, 9g of raw radix paeoniae alba, 9g of raw liquorice, 9g of radix bupleuri, 9g of cassia twig, 15g of codonopsis pilosula, 9g of perilla leaf, 9g of rhizoma anemarrhenae, 9g of schizonepeta spike, 9g of cortex mori radicis, 9g of sappan wood, 6g of fructus tsaoko, 9g of rhizoma dryopteris crassirhizomae and 15g of polygonum cuspidatum.
Mixing the above materials, pulverizing, collecting several powders each time, and heating by electronic incense burner.
Example 3:
9g of rhizoma atractylodis stir-fried with bran, 9g of cortex magnoliae officinalis processed with ginger, 9g of pericarpium citri reticulatae, 9g of radix glycyrrhizae preparata, 9g of rhizoma zingiberis, 9g of fructus aurantii, 9g of platycodon grandiflorum, 9g of raw radix paeoniae alba, 9g of raw liquorice, 9g of radix bupleuri, 9g of cassia twig, 15g of codonopsis pilosula, 9g of perilla leaf, 9g of rhizoma anemarrhenae, 9g of schizonepeta spike, 9g of cortex mori radicis, 9g of sappan wood, 6g of fructus tsaoko, 9g of rhizoma dryopteris crassirhizomae and 15g of polygonum cuspidatum.
Mixing the above materials, pulverizing, and making into sachet for wearing.
Example 4:
9g of rhizoma atractylodis stir-fried with bran, 9g of cortex magnoliae officinalis processed with ginger, 9g of pericarpium citri reticulatae, 9g of radix glycyrrhizae preparata, 9g of rhizoma zingiberis, 9g of fructus aurantii, 9g of platycodon grandiflorum, 9g of raw radix paeoniae alba, 9g of raw liquorice, 9g of radix bupleuri, 9g of cassia twig, 15g of codonopsis pilosula, 9g of perilla leaf, 9g of rhizoma anemarrhenae, 9g of schizonepeta spike, 9g of cortex mori radicis, 9g of sappan wood, 6g of fructus tsaoko, 9g of rhizoma dryopteris crassirhizomae and 15g of polygonum cuspidatum.
The medicines are added with water and decocted directly for fumigation.

Claims (1)

1. A traditional Chinese medicine formula with a prevention and treatment effect on 2019 novel coronavirus is characterized in that the formula is mainly prepared from the following raw material medicines: 3-9 parts of bran-fried rhizoma atractylodis, 3-9 parts of cortex magnoliae officinalis, 3-9 parts of pericarpium citri reticulatae, 3-9 parts of honey-fried licorice root, 3-9 parts of rhizoma zingiberis, 3-9 parts of fructus aurantii, 3-9 parts of platycodon grandiflorum, 6-15 parts of raw radix paeoniae alba, 6-9 parts of raw liquorice, 3-9 parts of radix bupleuri, 3-9 parts of cassia twig, 9-30 parts of codonopsis pilosula, 6-9 parts of perilla leaf, 6-12 parts of rhizoma anemarrhenae, 6-9 parts of schizonepeta spike, 6-12 parts of cortex mori radicis, 3-9 parts of sappan wood, 3-6 parts of fructus tsaoko, 6-9 parts of rhizoma dryopteris crassirhizomae and 9-15 parts of polygonum cuspidatum.
CN202210422176.0A 2022-04-21 2022-04-21 Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus Pending CN114796430A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210422176.0A CN114796430A (en) 2022-04-21 2022-04-21 Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210422176.0A CN114796430A (en) 2022-04-21 2022-04-21 Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus

Publications (1)

Publication Number Publication Date
CN114796430A true CN114796430A (en) 2022-07-29

Family

ID=82504651

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210422176.0A Pending CN114796430A (en) 2022-04-21 2022-04-21 Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus

Country Status (1)

Country Link
CN (1) CN114796430A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111467451A (en) * 2020-05-11 2020-07-31 劲牌持正堂药业有限公司 Composition and preparation for treating novel coronavirus pneumonia and application of composition and preparation
CN111671880A (en) * 2020-05-11 2020-09-18 首都医科大学附属北京中医医院 Traditional Chinese medicine preparation for treating fever caused by coronavirus pneumonia
CN112007139A (en) * 2020-09-25 2020-12-01 漯河市第一人民医院 Astragalus-cassia twig-poria traditional Chinese medicine mixture for treating cold-dampness lung-stasis type viral pneumonia
CN112353855A (en) * 2020-05-20 2021-02-12 广西壮族自治区花红药业股份有限公司 Application of traditional Chinese medicine composition in preparation of medicine for adjuvant therapy of novel coronavirus pneumonia

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111467451A (en) * 2020-05-11 2020-07-31 劲牌持正堂药业有限公司 Composition and preparation for treating novel coronavirus pneumonia and application of composition and preparation
CN111671880A (en) * 2020-05-11 2020-09-18 首都医科大学附属北京中医医院 Traditional Chinese medicine preparation for treating fever caused by coronavirus pneumonia
CN112353855A (en) * 2020-05-20 2021-02-12 广西壮族自治区花红药业股份有限公司 Application of traditional Chinese medicine composition in preparation of medicine for adjuvant therapy of novel coronavirus pneumonia
CN112007139A (en) * 2020-09-25 2020-12-01 漯河市第一人民医院 Astragalus-cassia twig-poria traditional Chinese medicine mixture for treating cold-dampness lung-stasis type viral pneumonia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王浚,王永睿,王永胜: "自拟桑柴平汤治疗病毒性感冒162例体会" *

Similar Documents

Publication Publication Date Title
CN103784820B (en) For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease
CN103768537B (en) Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris
CN101361952A (en) Traditional Chinese medicine preparation for treating cold
CN101129620A (en) Traditional Chinese medicine for treating nasosinusitis headache
CN1328834A (en) Capsule for curing cholecystitis
CN103638370A (en) Traditional Chinese medicine for treating dental ulcer
CN100400094C (en) Traditional Chinese medicine for treating hepatitis B and its preparing process
CN103784888A (en) Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis
CN100478020C (en) Stomatocase treating medicine
CN103720996A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN102205059A (en) Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof
CN101623352A (en) Medicine for treating acne and preparation method thereof
CN104758529A (en) Traditional Chinese medicine composition for treating common cold due to wind-cold
CN104587414A (en) Traditional Chinese medicinal composition for treating headache
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN100352487C (en) Pure Chinese medicine for treating chronic rhinitis, pharyngitis and globus hysterics
CN114796430A (en) Traditional Chinese medicine formula with effect of preventing and treating 2019 novel coronavirus
CN103385973B (en) Miao medicine for curing liver cancer and preparation method thereof
CN101856488A (en) Chinese medicament for treating tracheitis
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN102048930A (en) Formula of traditional Chinese medicine for treating chronic gastritis
CN1186056C (en) Medicine for treating osteoproliferation
CN101129654B (en) Orally taken traditional Chinese medicine for treating cerebral hemorrhage sequela
CN104758528A (en) Traditional Chinese medicine composition for treating headache

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination